T*R
11 楼
April 26 (Bloomberg) -- Charles River Laboratories International Inc. agreed
to buy WuXi PharmaTech (Cayman) Inc. for about $1.6 billion to expand in
China, where revenue from drug-testing services is growing as much as 30
percent a year.
Charles River will pay $21.25 a share, comprising $11.25 in cash and $10 in
stock, for each WuXi American depositary share, the companies said in a
statement today. The offer is 28 percent more than WuXi’s closing price of
$16.57 in New York Stock Exchange trad
【在 S******G 的大作中提到】
: 谢谢,哪里有联接?
to buy WuXi PharmaTech (Cayman) Inc. for about $1.6 billion to expand in
China, where revenue from drug-testing services is growing as much as 30
percent a year.
Charles River will pay $21.25 a share, comprising $11.25 in cash and $10 in
stock, for each WuXi American depositary share, the companies said in a
statement today. The offer is 28 percent more than WuXi’s closing price of
$16.57 in New York Stock Exchange trad
【在 S******G 的大作中提到】
: 谢谢,哪里有联接?
相关阅读
2017年第二届同济大学国际青年学者论坛—生命医学分论坛会议 第二轮通知看看国内的普遍收入吧,海归拿的算高收入了“神韵”一场挂羊头卖狗肉的低级秀现在国内就连中专技校毕业一个月3千低收入的都瞧不起美国了说个和钱有关,海归无关的故事富人都想方设法移民,平民相反在国内,养老金的确不是问题侯峰:25年弹指一挥间,中美沧海桑田 (转载)转一篇大陆的关于志愿军战俘的文章美国人作为灾民的悲惨生活 (转载)现在网上很多五毛,想海归的小心别被忽悠美国抑郁病高发,真该学习第三世界的穷开心 (转载)大洋狗又翻墙过来转载了现在海归是49年入国民党美国医疗的确太贵华人在讨论垃圾中国 (转载)分析仪器产品转让 (转载)谁说国内比美国安全?看看这个(ZT)中国准备和美国分道扬镳了 (转载)我的美国客户坚持要去台湾开会,拒绝香港和大陆,原来是因为 (转载)